Dube Eric M's Form 4 filing
Travere Therapeutics, Inc. (TVTX) · filed Apr 15, 2026
- Accession no.
- 0001763494-26-000005
- Filed
- Apr 15, 2026
- Trade date
- Apr 13-15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.63M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dube Eric MCIK 0001763494 | Director, Officer (CHIEF EXECUTIVE OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 13, 2026 | Common Stock | AGrant or awardAcquired | +64,000 | $0.00 | $0 | 496,886 | Direct | |
| Apr 15, 2026 | Common Stock | SSaleDisposed | −56,815 | $41.01 | −$2,329,983.15 | 440,071 | Direct | |
| Apr 15, 2026 | Common Stock | SSaleDisposed | −7,165 | $41.75 | −$299,138.75 | 432,906 | Direct | |
| Apr 15, 2026 | Common Stock | SSaleDisposed | −20 | $42.66 | −$853.2 | 432,886 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.